GREEN CROSS WellBeing Corporation (KOSDAQ:234690)
South Korea · Delayed Price · Currency is KRW 9,470.00
-30.00 (-0.32%)
At close: Mar 6, 2026
GREEN CROSS WellBeing Market Cap
GREEN CROSS WellBeing has a market cap or net worth of 158.82 billion as of March 9, 2026. Its market cap has increased by 0.98% in one year.
Market Cap
158.82B
Enterprise Value
224.21B
Revenue
151.06B
Ranking
n/a
PE Ratio
17.38
Stock Price
9,470.00
Market Cap Chart
Since October 14, 2019, GREEN CROSS WellBeing's market cap has decreased from 221.90B to 158.82B, a decrease of -28.43%. That is a compound annual growth rate of -5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 168.05B | 3.61% |
| Dec 30, 2025 | 162.19B | -9.18% |
| Dec 30, 2024 | 178.59B | 23.74% |
| Dec 28, 2023 | 144.33B | -1.22% |
| Dec 29, 2022 | 146.10B | -18.92% |
| Dec 30, 2021 | 180.19B | -27.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NOVAREX | 225.53B |
| Vivozon Pharmaceutical | 196.71B |
| Organoidsciences | 187.36B |
| OPTUS Pharmaceutical | 186.35B |
| High Tech Pharm | 166.94B |
| Kyung Dong Pharmaceutical | 148.18B |
| DongKoo Bio & Pharma | 145.49B |
| KOREA PHARMA | 138.95B |